Clinical trial

Modification of Chronic Inflammation by Inhaled Carbon Monoxide in Patients With…

NCT00122694 · Groningen Research Institute for Asthma and COPD, Other · Completed

Key facts

NCT number NCT00122694
Title Modification of Chronic Inflammation by Inhaled Carbon Monoxide in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)
Official title Modification of Chronic Inflammation by Inhaled Carbon Monoxide in Patients With Stable COPD
Lead sponsor Groningen Research Institute for Asthma and COPD, Other
Collaborators Stichting Astma Bestrijding, The Netherlands
Status Completed
Phase Phase 2
Study type Interventional
Conditions Pulmonary Disease, Chronic Obstructive
Intervention type Drug
Interventions carbon monoxide
Enrollment 20
Start date Jan 1, 2005
Completion Mar 1, 2006
First posted Jul 22, 2005
Last update posted Sep 12, 2006
Countries Netherlands

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies